Notably, we observed a high mutation frequency of PIK3CA in CRC samples based on the mutation profiles of ICD-associated genes, suggesting that PIK3CA mutations may influence CRC growth and progression via DAMPs, by altering the tumor’s immune response. The gene discussed is PIK3CA; the disease is neoplasm.